The data collected in FAERS is used in various ways:
Detecting safety signals: Identifying new or rare adverse events that were not observed in clinical trials. Risk assessment: Evaluating the frequency and severity of known adverse events. Regulatory actions: Informing decisions on labeling changes, product recalls, and other regulatory actions to ensure product safety. Research: Providing valuable data for epidemiological studies and research on drug safety.
